EUVIMEDEUVIMED entdecken
Crossref

Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death

Run-Run Shan, Ju-Tao Yu, Shao-Fei Zhang, Man-Man Xie, Rui Hou, Chun-Ya Xie, Ze-Hui Dong, Qin Yang, Xiao-Wei Hu, Yu-Hang Dong, Yao Zhang, Xiu-Feng Luo und 8 weitere

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2023.155252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Run-Run Shan und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Anhui Medical University, Hefei, 230032, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the …. Hauptthemen laut MEDLINE: Acute Kidney Injury, Reperfusion Injury, Triterpenes. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute kidney injury (AKI) has high morbidity and mortality, which is manifested by inflammation and apoptosis. Effective treatment methods for AKI are currently lacking. OBJECTIVE: This study demonstrated the protecting effects of Madecassoside (MA) in the cisplatin- and hypoxia-reoxygenation-induced renal tubular epithelial cells in vitro and AKI mice in vivo. METHODS: In vivo AKI mouse models were established by inducing them with cisplatin and renal ischemia-reperfusion. In vitro injury models of mouse renal tubular epithelial cells were established by inducing them with cisplatin and hypoxia and reoxygenation, respectively. The mechanism of MA effects was further explored using molecular docking and RNA-sequencing. RESULTS: MA could significantly reduce kidney injury in the cisplatin-and renal ischemia-reperfusion (IRI)-induced AKI. Further validation in the two cellular models also showed that MA had protect effects. MA can alleviate AKI in vitro and in vivo by inhibiting inflammation, cell apoptosis, and oxidative stress. MA exhibited high permeability across the Caco-2 cell, can enter cells directly. Through RNA-seq and molecular docking analysis, this study further demonstrated that MA inhibits its activity by directly binding to JNK kinase, thereby inhibiting c-JUN mediated cell apoptosis and improving AKI. In addition, MA has better renal protective effects compared to curcumin and JNK inhibitor SP600125. CONCLUSION: The results demonstrate that MA might be a potential drug for the treatment of AKI and act through the JNK/c-JUN signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryReperfusion InjuryTriterpenesHumansMiceAnimalsCisplatinCaco-2 CellsMolecular Docking SimulationApoptosisKidneyOxidative StressIschemiaInflammationHypoxiaMice, Inbred C57BL

Stichwörter der Autor:innen

Acute kidney injuryApoptosisInflammationJNKMadecassoside

Substanzen

madecassosideCisplatinTriterpenes

Autor:innen und Institutionen

  • School of Life Sciences, Anhui Medical University, Hefei, 230032, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of E…
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui…
  • School of Life Sciences, Anhui Medical University, Hefei, 230032, China.
  • Department of Clinical Pharmacology, Second Hospital of Anhui Medical University, 678 Furong Road, Hefei, 230601, Anhui, China.
  • Department of Clinical Pharmacy, Anhui provincial Children's Hospital, Hefei, 230051, China.
  • Anqing First People's Hospital of Anhui Medical University, Anqing, 246000, China.

Zitieren

APA

Shan, R. R., Yu, J. T., Zhang, S. F., Xie, M. M., Hou, R., Xie, C. Y., Dong, Z. H., Yang, Q., Hu, X. W., Dong, Y. H., Zhang, Y., Luo, X. F., Cui, Z. Y., Liu, X. Y., Xie, Y. C., Wen, J. G., Liu, M. M., Jin, J., Chen, Q., & Meng, X. M. (2024). Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death. Phytomedicine. https://doi.org/10.1016/j.phymed.2023.155252

Vancouver

Shan RR, Yu JT, Zhang SF, Xie MM, Hou R, Xie CY, et al. Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death. Phytomedicine. 2024. doi:10.1016/j.phymed.2023.155252

BibTeX
@article{Shan2024,
  author = {Shan, Run-Run and Yu, Ju-Tao and Zhang, Shao-Fei and Xie, Man-Man and Hou, Rui and Xie, Chun-Ya and Dong, Ze-Hui and Yang, Qin and Hu, Xiao-Wei and Dong, Yu-Hang and Zhang, Yao and Luo, Xiu-Feng and Cui, Zong-Yu and Liu, Xiao-Ying and Xie, Yun-Chang and Wen, Jia-Gen and Liu, Ming-Ming and Jin, Juan and Chen, Qi and Meng, Xiao-Ming},
  title = {Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2023.155252}
}
Kostenlos starten →